Autres langues Psyence Group Inc.

Actions

PSYG

CA74449Q1063

Temps Différé Canadian Securities Exchange Autres places de cotation 19:03:18 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,02 ^CAD	0,00%		0,00%	-60,00%

26/03	Un acheteur non divulgué a conclu l'acquisition de Mind Health (Pty) Ltd et de Psyence Uk Group Ltd auprès de Psyence Group Inc. (CNSX:PSYG).	CI
11/03	Le Groupe Psyence Inc. annonce la démission de Neil Maresky en tant que PDG	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	16/04
Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	26/03
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business	26/03
An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	26/03
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	12/03
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	12/03
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11/03
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11/03
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11/03
Psyence Group Inc. Announces Resignation of Neil Maresky as CEO	11/03
Psyence Group Inc. Announces CFO Changes	11/03
Psyence Group Inc. Announces Board Resignations	11/03
An undisclosed buyer entered into a conditional agreement to acquire Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc. for CAD 1 million.	11/03
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28/02
Psyence Biomedical Approved to List on Nasdaq Following Completion of Business Combination With Newcourt Acquisition Corp	26/01
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	26/01
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	25/01
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination	16/01
Psyence Group Inc. Announces Resignation of Marvin Singer as Board Member	20/11
Psyence Group Announces Resignation of Board Member	20/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Psyence Group Inc.

Actions

PSYG

CA74449Q1063

Autres langues

Filtres